New painkiller cebranopadol tested for Post-Surgery relief
NCT ID NCT06423703
First seen Jan 10, 2026 · Last updated May 25, 2026 · Updated 26 times
Summary
This study tested a new pain medicine called cebranopadol in 240 adults who had bunion surgery. The goal was to see if it safely reduces moderate to severe pain better than a placebo or another painkiller. Participants rated their pain and satisfaction, and researchers tracked how many needed extra rescue medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ALLEVIATE 2 Site 001101
Salt Lake City, Utah, 84107, United States
-
ALLEVIATE 2 Site 001102
Atlanta, Georgia, 30331, United States
-
ALLEVIATE 2 Site 001103
Tampa, Florida, 33613, United States
-
ALLEVIATE 2 Site 001104
McAllen, Texas, 78501, United States
-
ALLEVIATE 2 Site 001105
Pasadena, Maryland, 21122, United States
-
ALLEVIATE 2 Site 001106
Little Rock, Arkansas, 72211, United States
-
ALLEVIATE 2 Site 001107
Overland Park, Kansas, 66212, United States
-
ALLEVIATE 2 Site 001108
Sheffield, Alabama, 35660, United States
-
ALLEVIATE 2 Site 001111
San Antonio, Texas, 78240, United States
-
Alleviate 2 001113
Houston, Texas, 77043, United States
Conditions
Explore the condition pages connected to this study.